Case Report (n=1)
No
Multidisciplinary planning and careful access assessment can enable safe and successful Impella-supported high-risk PCI via femoral access even in patients with severe peripheral arterial disease and prior iliac stenting.
Careful access assessment enables safe femoral Impella use in high-risk PCI despite prior iliac stenting; extends options in severe PAD but remains hypothesis-generating.
We present the case of an 80-year-old male patient with heart failure with reduced ejection fraction and heavily calcified, multi-vessel coronary artery disease involving the distal left main, left anterior descending, and left circumflex arteries, along with a chronic total occlusion of the right coronary artery. He was turned down for surgical revascularization with coronary artery bypass grafting. He initially remained stable on medical therapies and underwent implantable cardioverter defibrillator implantation. He presented back with ventricular fibrillation. Repeat angiography demonstrated progression of his disease. He was planned for high-risk percutaneous coronary intervention supported by a transcatheter micro-axial flow pump. Given his history of peripheral arterial disease (PAD) with prior iliac stenting, vascular surgery was consulted to facilitate large-bore access to initiate support, ultimately deciding on bilateral femoral arterial access.
No takes yet. Share an insight, caveat, or question.
Appareddy et al. (2026) conducted a case report in Elderly male patient (80 years) with heart failure with reduced ejection fraction (LVEF 20-25%), progressive multi-vessel heavily calcified coronary artery disease including unprotected distal left main, and prior bilateral iliac artery stenting for peripheral arterial disease (n=1). Impella CP mechanical circulatory support device with high-risk percutaneous coronary intervention employing rotational atherectomy, intravascular lithotripsy, and double-kissing crush two-stent strategy was evaluated on Successful high-risk PCI supported by Impella device with no intra-procedural complications and freedom from recurrent ventricular arrhythmias or angina at 3 months follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: